Skip to main content

Advertisement

Log in

The Role of Methylation of a Group of microRNA Genes in the Pathogenesis of Metastatic Renal Cell Carcinoma

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The role of methylation of 9 miRNA genes in the pathogenesis of metastatic clear cell renal cell carcinoma was determined by quantitative methylation-specific PCR (MS-PCR). For 5 genes (MIR125B-1, MIR137, MIR193A, MIR34B/C, and MIR375), a significant correlation of high methylation level with late (III-IV) stages, large size (T3+T4) of the tumor, and metastasis to lymph nodes and/or distant organs was revealed. For another group of genes (MIR125B-1, MIR1258, MIR193A, MIR34B/C, and MIR375), a statistically significant correlation of high methylation level with loss of differentiation in the tumor (G3-G4) was found, and the opposite pattern was found for MIR203A. A total of 7 microRNA genes (MIR125B-1, MIR1258, MIR137, MIR193A, MIR203A, MIR34B/C, and MIR375) were identified, the methylation of which is associated with the progression of metastatic clear cell renal cell carcinoma. For 6 of them (except MIR34B/C) these data were obtained for the first time. Thus, new factors of the development and progression of clear cell renal cell carcinoma were identified as potential biomarkers for the early diagnosis and prognosis of metastatic clear cell renal cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, Gavin A, Flego M, Neamtiu L, Dimitrova N, Negrão Carvalho R, Ferlay J, Bettio M. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur. J. Cancer. 2021;157:308-347. doi: https://doi.org/10.1016/j.ejca.2021.07.039

    Article  PubMed  PubMed Central  Google Scholar 

  2. Zaridze DG, Kaprin AD, Stilidi IS. Dynamics of morbidity and mortality from malignant tumors in Russia. Voprosy Onkol. 2018;64(5):578-591. Russian. doi: https://doi.org/10.37469/0507-3758-2018-64-5-578-591

  3. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG; Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WM. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018;23(1):313-326.e5. doi: https://doi.org/10.1016/j.celrep.2018.03.075

  4. Popławski P, Bogusławska J, Hanusek K, Piekiełko-Witkowska A. Nucleolar proteins and non-coding RNAs: roles in renal cancer. Int. J. Mol. Sci. 2021;22(23):13126. doi: https://doi.org/10.3390/ijms222313126

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Öztürk H. Bilateral synchronous adrenal metastases of renal cell carcinoma: A case report and review of the literature. Oncol. Lett. 2015;9(4):1897-1901. doi: https://doi.org/10.3892/ol.2015.2915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Costantino C, Thomas GV, Ryan C, Coakley FV, Troxell ML. Metastatic renal cell carcinoma without evidence of a renal primary. Int. Urol. Nephrol. 2016;48(1):73-77. doi: https://doi.org/10.1007/s11255-015-1145-3

    Article  CAS  PubMed  Google Scholar 

  7. Alecki C, Vera M. Role of nuclear non-canonical nucleic acid structures in organismal development and adaptation to stress conditions. Front. Genet. 2022;13:823241. doi: https://doi.org/10.3389/fgene.2022.823241

  8. Braga EA, Fridman MV, Loginov VI, Dmitriev AA, Morozov SG. Molecular mechanisms in clear cell renal cell carcinoma: role of miRNAs and hypermethylated miRNA genes in crucial oncogenic pathways and processes. Front. Genet. 2019;10:320. doi: https://doi.org/10.3389/fgene.2019.00320

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hanahan D. Rethinking the war on cancer. Lancet. 2014;383:558-563. doi: https://doi.org/10.1016/S0140-6736(13)62226-6

    Article  PubMed  Google Scholar 

  10. Pfeifer GP. Defining driver DNA methylation changes in human cancer. Int. J. Mol. Sci. 2018;19(4):1166. doi: https://doi.org/10.3390/ijms19041166

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. TNM Classification of Malignant Tumours. Brierley JD, Gospodarowicz MK, Wittekind C, eds. Oxford; Hoboken, 2017.

  12. Loginov VI, Burdennyy AM, Filippova EA, Pronina IV, Lukina SS, Kazubskaya TP, Karpukhin AV, Khodyrev DS, Braga EA. Aberrant methylation of 21 microRNA genes in breast cancer: sets of genes associated with progression and a system of markers for predicting metastasis. Bull. Exp. Biol. Med. 2021;172(1):67-71. doi: https://doi.org/10.1007/s10517-021-05333-x

    Article  CAS  PubMed  Google Scholar 

  13. Apanovich NV, Loginov VI, Filippova EA, Khodyrev DS, Burdennyy AM, Pronina IV, Ivanova NA, Lukina SS, Kazubskaya TP, Matveev VB, Karpukhin AV, Braga EA. Methylation of a group of microRNA genes: markers of renal cell carcinoma metastasis. Onkourologiya. 2020;16(4):32-38. Russian. doi: https://doi.org/10.17650/1726-9776-2020-16-4-32-38

  14. Filippova EA, Pronina IV, Lukina SS, Kazubskaya TP, Braga EA, Burdennyi AM, Loginov VI. Relationship of the Levels of microRNA gene methylation with the level of their expression and pathomorphological characteristics of breast cancer. Bull. Exp. Biol. Med. 2021;171(6):764-769. doi: https://doi.org/10.1007/s10517-021-05312-2

    Article  CAS  PubMed  Google Scholar 

  15. Loginov VI, Pronina IV, Filippova EA, Burdennyy AM, Lukina SS, Kazubskaya TP, Uroshlev LA, Fridman MV, Brovkina OI, Apanovich NV, Karpukhin AV, Stilidi IS, Kushlinskii NE, Dmitriev AA, Braga EA. Aberrant methylation of 20 miRNA genes specifically involved in various steps of ovarian carcinoma spread: from primary tumors to peritoneal macroscopic metastases. Int. J. Mol. Sci. 2022;23(3):1300. doi: https://doi.org/10.3390/ijms23031300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. M. Burdennyi.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 175, No. 2, pp. 215-219, February, 2023

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ivanova, N.A., Burdennyi, A.M., Lukina, S.S. et al. The Role of Methylation of a Group of microRNA Genes in the Pathogenesis of Metastatic Renal Cell Carcinoma. Bull Exp Biol Med 175, 249–253 (2023). https://doi.org/10.1007/s10517-023-05844-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-023-05844-9

Keywords

Navigation